Annual FCF
-$55.41 M
+$13.84 M+19.98%
31 December 2021
Summary:
Concert Pharmaceuticals annual free cash flow is currently -$55.41 million, with the most recent change of +$13.84 million (+19.98%) on 31 December 2021. During the last 3 years, it has risen by +$13.84 million (+19.98%).CNCE Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly FCF
-$26.05 M
-$1.07 M-4.30%
30 September 2022
Summary:
Concert Pharmaceuticals quarterly free cash flow is currently -$26.05 million, with the most recent change of -$1.07 million (-4.30%) on 30 September 2022.CNCE Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM FCF
-$109.94 M
-$7.32 M-7.13%
30 September 2022
Summary:
Concert Pharmaceuticals TTM free cash flow is currently -$109.94 million, with the most recent change of -$7.32 million (-7.13%) on 30 September 2022.CNCE TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CNCE Free Cash Flow Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | - | - |
| 3 y3 years | +20.0% | -39.1% | -143.4% |
| 5 y5 years | -8.9% | -65.9% | -118.7% |
CNCE Free Cash Flow High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | ||||||
| 5 y | 5 years | ||||||
| alltime | all time | -153.7% | -119.5% | -205.5% |
Concert Pharmaceuticals Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2022 | - | -$26.05 M(+4.3%) | -$109.94 M(+7.1%) |
| June 2022 | - | -$24.98 M(-22.9%) | -$102.63 M(+53.1%) |
| Mar 2022 | - | -$32.42 M(+22.4%) | -$67.02 M(+21.0%) |
| Dec 2021 | -$55.41 M(-20.0%) | -$26.49 M(+41.4%) | -$55.41 M(+22.7%) |
| Sept 2021 | - | -$18.73 M(-276.3%) | -$45.17 M(-3.4%) |
| June 2021 | - | $10.63 M(-151.1%) | -$46.78 M(-35.1%) |
| Mar 2021 | - | -$20.81 M(+28.0%) | -$72.11 M(+4.1%) |
| Dec 2020 | -$69.25 M(+40.0%) | -$16.25 M(-20.1%) | -$69.25 M(+1.5%) |
| Sept 2020 | - | -$20.34 M(+38.4%) | -$68.23 M(+7.3%) |
| June 2020 | - | -$14.70 M(-18.1%) | -$63.60 M(-3.3%) |
| Mar 2020 | - | -$17.95 M(+17.7%) | -$65.74 M(+33.0%) |
| Dec 2019 | -$49.45 M(-2.9%) | -$15.24 M(-3.0%) | -$49.45 M(-1.7%) |
| Sept 2019 | - | -$15.71 M(-6.7%) | -$50.28 M(+7.7%) |
| June 2019 | - | -$16.84 M(+919.0%) | -$46.67 M(+17.4%) |
| Mar 2019 | - | -$1.65 M(-89.7%) | -$39.74 M(-21.9%) |
| Dec 2018 | -$50.90 M(-149.3%) | -$16.08 M(+32.9%) | -$50.90 M(+22.7%) |
| Sept 2018 | - | -$12.09 M(+22.0%) | -$41.47 M(-139.8%) |
| June 2018 | - | -$9.92 M(-22.6%) | $104.17 M(+0.5%) |
| Mar 2018 | - | -$12.81 M(+92.7%) | $103.62 M(+0.5%) |
| Dec 2017 | $103.14 M | -$6.65 M(-105.0%) | $103.14 M(+5.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2017 | - | $133.55 M(-1375.9%) | $97.81 M(-312.3%) |
| June 2017 | - | -$10.47 M(-21.3%) | -$46.07 M(+2.7%) |
| Mar 2017 | - | -$13.30 M(+11.1%) | -$44.85 M(-2.7%) |
| Dec 2016 | -$46.11 M(-307.8%) | -$11.97 M(+15.8%) | -$46.11 M(+38.7%) |
| Sept 2016 | - | -$10.34 M(+11.8%) | -$33.25 M(+6.8%) |
| June 2016 | - | -$9.24 M(-36.5%) | -$31.13 M(-265.4%) |
| Mar 2016 | - | -$14.56 M(-1736.2%) | $18.82 M(-15.2%) |
| Dec 2015 | $22.19 M(-172.6%) | $890.00 K(-110.8%) | $22.19 M(+74.0%) |
| Sept 2015 | - | -$8.21 M(-120.2%) | $12.75 M(-11.1%) |
| June 2015 | - | $40.70 M(-463.9%) | $14.35 M(-142.8%) |
| Mar 2015 | - | -$11.19 M(+30.8%) | -$33.55 M(+9.8%) |
| Dec 2014 | -$30.56 M(-341.5%) | -$8.55 M(+29.2%) | -$30.56 M(+9.7%) |
| Sept 2014 | - | -$6.62 M(-8.1%) | -$27.86 M(-5.0%) |
| June 2014 | - | -$7.20 M(-12.1%) | -$29.34 M(-542.8%) |
| Mar 2014 | - | -$8.20 M(+40.3%) | $6.63 M(-47.6%) |
| Dec 2013 | $12.65 M(-147.1%) | -$5.84 M(-27.8%) | $12.65 M(-31.6%) |
| Sept 2013 | - | -$8.10 M(-128.2%) | $18.50 M(-30.4%) |
| June 2013 | - | $28.76 M(-1428.4%) | $26.59 M(-1328.4%) |
| Mar 2013 | - | -$2.17 M | -$2.17 M |
| Dec 2012 | -$26.89 M(+46.4%) | - | - |
| Dec 2011 | -$18.38 M | - | - |
FAQ
- What is Concert Pharmaceuticals annual free cash flow?
- What is the all time high annual FCF for Concert Pharmaceuticals?
- What is Concert Pharmaceuticals quarterly free cash flow?
- What is the all time high quarterly FCF for Concert Pharmaceuticals?
- What is Concert Pharmaceuticals TTM free cash flow?
- What is the all time high TTM FCF for Concert Pharmaceuticals?
What is Concert Pharmaceuticals annual free cash flow?
The current annual FCF of CNCE is -$55.41 M
What is the all time high annual FCF for Concert Pharmaceuticals?
Concert Pharmaceuticals all-time high annual free cash flow is $103.14 M
What is Concert Pharmaceuticals quarterly free cash flow?
The current quarterly FCF of CNCE is -$26.05 M
What is the all time high quarterly FCF for Concert Pharmaceuticals?
Concert Pharmaceuticals all-time high quarterly free cash flow is $133.55 M
What is Concert Pharmaceuticals TTM free cash flow?
The current TTM FCF of CNCE is -$109.94 M
What is the all time high TTM FCF for Concert Pharmaceuticals?
Concert Pharmaceuticals all-time high TTM free cash flow is $104.17 M